0001551306-24-000055.txt : 20240403
0001551306-24-000055.hdr.sgml : 20240403
20240403171658
ACCESSION NUMBER: 0001551306-24-000055
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240304
FILED AS OF DATE: 20240403
DATE AS OF CHANGE: 20240403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Livingston Mark S.
CENTRAL INDEX KEY: 0001824161
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39100
FILM NUMBER: 24820074
MAIL ADDRESS:
STREET 1: C/O PROGYNY, INC.
STREET 2: 1359 BROADWAY, 2ND FL
CITY: NEW YORK
STATE: NY
ZIP: 10018
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Progyny, Inc.
CENTRAL INDEX KEY: 0001551306
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 272220139
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1359 BROADWAY
STREET 2: 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
BUSINESS PHONE: 212-888-3124
MAIL ADDRESS:
STREET 1: 1359 BROADWAY
STREET 2: 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
FORMER COMPANY:
FORMER CONFORMED NAME: Auxogyn, Inc.
DATE OF NAME CHANGE: 20150318
FORMER COMPANY:
FORMER CONFORMED NAME: Auxogyn Inc
DATE OF NAME CHANGE: 20120601
4
1
wk-form4_1712179007.xml
FORM 4
X0508
4
2024-03-04
0
0001551306
Progyny, Inc.
PGNY
0001824161
Livingston Mark S.
C/O PROGYNY, INC.
1359 BROADWAY, 2ND FL
NEW YORK
NY
10018
0
1
0
0
CHIEF FINANCIAL OFFICER
1
Common Stock
2024-03-04
4
A
0
15000
0
A
52248
D
Common Stock
2024-04-01
4
M
0
20627
3.95
A
72875
D
Common Stock
2024-04-01
4
F
0
11591
37.643
D
61284
D
Common Stock
2024-04-01
4
S
0
2129
37.60
D
59155
D
Common Stock
2024-04-01
4
S
0
9036
37.6194
D
50119
D
Stock Option (Right to Buy)
35.48
2024-03-04
4
A
0
45000
0
A
2034-03-03
Common Stock
45000
45000
D
Stock Option (Right to Buy)
3.95
2024-04-01
4
M
0
20627
0
D
2029-06-03
Common Stock
20627
0
D
Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). This was an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. 25% of the RSUs will vest on March 4, 2025 with the remaining RSUs vesting in equal quarterly installments thereafter through March 4, 2028, subject to the Reporting Person's continued service through each applicable vesting date.
Shares withheld for payment of withholding taxes upon the exercise of stock options granted to the Reporting Person.
Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 7, 2023.
Represents an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. 25% of the shares subject to the option will vest on March 4, 2025 with the remaining shares subject to the option vesting in equal quarterly installments thereafter through March 4, 2028, subject to the Reporting Person's continued service through each applicable vesting date.
These options are fully vested and exercisable.
/s/ Mark S. Livingston
2024-04-03